Digitisation | April 19, 2024
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
Around 7% of the Indian population suffers from IBS
Around 7% of the Indian population suffers from IBS
CHL is strengthening its play in the fast-growing beauty and personal care sector
New leadership team announced at NATHEALTH Annual General Meeting 2024
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Pharma Solutions operates 10 research and development and/or production sites globally
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The investment will catalyse various components of the IndiaAI Mission
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Subscribe To Our Newsletter & Stay Updated
